- Home
- GH vs CDE Comparison
GH vs CDE Comparison
Compare GH & CDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- CDE
- Stock Information
- Founded
- GH 2011
- CDE 1928
- Country
- GH United States
- CDE United States
- Employees
- GH N/A
- CDE N/A
- Industry
- GH Medical Specialities
- CDE Precious Metals
- Sector
- GH Health Care
- CDE Basic Materials
- Exchange
- GH Nasdaq
- CDE Nasdaq
- Market Cap
- GH 5.5B
- CDE 4.9B
- IPO Year
- GH 2018
- CDE N/A
- Fundamental
- Price
- GH $40.62
- CDE $8.08
- Analyst Decision
- GH Strong Buy
- CDE Strong Buy
- Analyst Count
- GH 21
- CDE 4
- Target Price
- GH $52.81
- CDE $8.00
- AVG Volume (30 Days)
- GH 2.3M
- CDE 17.7M
- Earning Date
- GH 04-30-2025
- CDE 05-07-2025
- Dividend Yield
- GH N/A
- CDE N/A
- EPS Growth
- GH N/A
- CDE N/A
- EPS
- GH N/A
- CDE 0.28
- Revenue
- GH $773,996,000.00
- CDE $1,201,008,000.00
- Revenue This Year
- GH $23.05
- CDE $60.06
- Revenue Next Year
- GH $21.40
- CDE $1.36
- P/E Ratio
- GH N/A
- CDE $28.65
- Revenue Growth
- GH 28.20
- CDE 41.80
- 52 Week Low
- GH $20.14
- CDE $4.57
- 52 Week High
- GH $52.92
- CDE $8.46
- Technical
- Relative Strength Index (RSI)
- GH 48.45
- CDE 66.66
- Support Level
- GH $37.73
- CDE $7.65
- Resistance Level
- GH $39.63
- CDE $8.46
- Average True Range (ATR)
- GH 1.60
- CDE 0.31
- MACD
- GH -0.01
- CDE 0.05
- Stochastic Oscillator
- GH 60.00
- CDE 70.61
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About CDE Coeur Mining Inc.
Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada, and Mexico.